[HTML][HTML] Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory, TC Wind… - British journal of …, 2012 - nature.com
Background: Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
[HTML][HTML] Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory… - British Journal of …, 2012 - ncbi.nlm.nih.gov
Background: Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
[PDF][PDF] Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory… - British Journal of …, 2012 - scienceopen.com
BACKGROUND: Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). METHODS …
existing clinicopathological models are needed in renal cell carcinoma (RCC). METHODS …
[PDF][PDF] Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory… - British Journal of …, 2012 - researchgate.net
BACKGROUND: Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). METHODS …
existing clinicopathological models are needed in renal cell carcinoma (RCC). METHODS …
[引用][C] Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH SIM, MP MESSENGER… - British journal of …, 2012 - pascal-francis.inist.fr
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP
in renal cell carcinoma CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
in renal cell carcinoma CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF][PDF] Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory… - British Journal of …, 2012 - cyberleninka.org
BACKGROUND: Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). METHODS …
existing clinicopathological models are needed in renal cell carcinoma (RCC). METHODS …
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.
SH Sim, MP Messenger, WM Gregory… - British Journal of …, 2012 - europepmc.org
Background Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.
SH Sim, MP Messenger, WM Gregory… - British Journal of …, 2012 - search.ebscohost.com
Background: Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory… - British journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Objectively measured circulating biomarkers of prognosis complementing
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …
existing clinicopathological models are needed in renal cell carcinoma (RCC). Methods …